260 related articles for article (PubMed ID: 34009012)
1. PARP1 Is Targeted by miR-519a-3p and Promotes the Migration, Invasion, and Tube Formation of Ovarian Cancer Cells.
Chang H; Zhang X; Li B; Meng X
Cancer Biother Radiopharm; 2022 Nov; 37(9):824-836. PubMed ID: 34009012
[No Abstract] [Full Text] [Related]
2. MiR-205 Promotes the Viability, Migration, and Tube Formation of Cervical Cancer Cells
Han H; Xu X
Cancer Biother Radiopharm; 2022 Nov; 37(9):779-791. PubMed ID: 33784470
[No Abstract] [Full Text] [Related]
3. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
Zheng J; Zhou Y; Li XJ; Hu JM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
[TBL] [Abstract][Full Text] [Related]
5. DNM3OS Facilitates Ovarian Cancer Progression by Regulating miR-193a-3p/MAP3K3 Axis.
He L; He G
Yonsei Med J; 2021 Jun; 62(6):535-544. PubMed ID: 34027641
[TBL] [Abstract][Full Text] [Related]
6. MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer.
Wang Z; Zhang X; Liu Y; Shi X; Li L; Jia Y; Wu F; Cui H; Li L
Histol Histopathol; 2023 Dec; 38(12):1403-1413. PubMed ID: 36825753
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30.
Liu Q; Yang H; Hua H
Reprod Biol; 2022 Jun; 22(2):100610. PubMed ID: 35313261
[TBL] [Abstract][Full Text] [Related]
8. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
10. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LINC01232 Enhances Proliferation, Angiogenesis, Migration and Invasion of Colon Adenocarcinoma Cells by Downregulating miR-181a-5p.
Yuan Y; Long Z
J Microbiol Biotechnol; 2023 Mar; 33(3):398-409. PubMed ID: 36655275
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA Small Nucleolar RNA Host Gene 3 Mediates Prostate Cancer Migration, Invasion, and Epithelial-Mesenchymal Transition by Sponging miR-487a-3p to Regulate
Yu L; Ren Y
Cancer Biother Radiopharm; 2022 Aug; 37(6):451-465. PubMed ID: 33416420
[No Abstract] [Full Text] [Related]
13. Long noncoding RNA FTX promotes epithelial-mesenchymal transition of epithelial ovarian cancer through modulating miR-7515/TPD52 and activating Met/Akt/mTOR.
Li Y; Zhu X; Zhang C; Yin Y; Chen L; Liu Y; He A; Xia F
Histol Histopathol; 2023 Dec; 38(12):1487-1498. PubMed ID: 37140169
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
15. MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH.
Wang Y; Dong L; Wan F; Chen F; Liu D; Chen D; Long J
Cell Death Dis; 2021 Sep; 12(10):861. PubMed ID: 34552061
[TBL] [Abstract][Full Text] [Related]
16. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
Shi Y; Yan F; Wang F; Pan L
Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
[TBL] [Abstract][Full Text] [Related]
17. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
[TBL] [Abstract][Full Text] [Related]
18. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.
Sun M; Chen Y; Liu X; Cui Y
Bioengineered; 2021 Dec; 12(1):8006-8019. PubMed ID: 34595994
[TBL] [Abstract][Full Text] [Related]
19. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p.
Wang L; Ren C; Xu Y; Yang L; Chen Y; Zhu Y
J Ovarian Res; 2021 Jun; 14(1):77. PubMed ID: 34116704
[TBL] [Abstract][Full Text] [Related]
20. microRNA-324-3p suppresses the aggressive ovarian cancer by targeting
Li F; Liang Z; Jia Y; Zhang P; Ling K; Wang Y; Liang Z
Bioengineered; 2022 May; 13(5):12030-12044. PubMed ID: 35549643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]